Private Capital Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$551K | – | 96 |
|
|
2018
Q1 | $551K | Sell |
10,000
-29,397
| -75% | -$1.62M | 0.18% | 68 |
|
|
2017
Q4 | $2.21M | Buy |
39,397
+29,401
| +294% | +$1.65M | 0.77% | 37 |
|
|
2017
Q3 | $612K | Sell |
9,996
-10,004
| -50% | -$612K | 0.21% | 72 |
|
|
2017
Q2 | $1.07M | Sell |
20,000
-20,372
| -50% | -$1.09M | 0.35% | 64 |
|
|
2017
Q1 | $1.95M | Buy |
+40,372
| New | +$1.95M | 0.64% | 44 |
|
|
2016
Q4 | – | Sell |
-17,140
| Closed | -$831K | – | 119 |
|
|
2016
Q3 | $831K | Buy |
+17,140
| New | +$831K | 0.3% | 65 |
|